主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANIP
#1862
ANI Pharmaceuticals, Inc.
73.900
0
-2.95%
版块:
基础:
利润货币:
日范围
年范围
日变化
-2.95%
每月变动
-7.56%
6个月变化
-21.91%
年变化
-21.91%
前一天收盘价
76.145
0
Open
73.900
0
Bid
Ask
Low
73.900
0
High
73.900
0
交易量
73
市场
股票
医疗保健
ANIP
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
21.02 M
21.76 M
21.65 M
21.69 M
22.46 M
22.41 M
—
Valuation ratios
Enterprise value
3.62 B
3.47 B
4.2 B
4.03 B
5.91 B
3.25 B
17.4 B
Price to earnings ratio
-142.05
-53.15
-63.76
-114.47
53.88
23.78
-100.58
Price to sales ratio
2.05
1.74
1.94
1.73
2.24
—
—
Price to cash flow ratio
12.07
16.68
16.29
9.4
10.92
9.05
45.65
Price to book ratio
0.65
2.65
0.78
0.77
1.05
3.1
5.7
Enterprise value to EBITDA ratio
13.36
7.92
15.27
13.36
22.69
—
—
Profitability ratios
Return on assets %
-0.01
-0.01
0.01
0.01
0.02
0.02
0.06
Return on equity %
-0.03
-0.03
0.04
0.02
0.05
0.05
0.16
Return on invested capital %
-7.47
-1.16
7.62
4.22
10.77
11.38
34
Gross margin %
57.48
57.87
62.95
64.7
59.01
59.42
246.07
Operating margin %
-13.83
-2.3
13.29
6.57
15.91
14.07
49.84
EBITDA margin %
71.99
40.38
29.43
28.33
28.84
54.19
140.79
Net margin %
-8.26
-5.39
7.95
4.04
11.68
11.13
34.81
Liquidity ratios
Quick ratio
1.97
2.02
1.98
1.96
2.04
2.19
8.17
Current ratio
2.74
2.72
2.66
2.54
2.58
2.71
10.49
Inventory turnover
0.46
0.56
0.53
0.54
0.66
0.69
2.42
Asset turnover
0.13
0.15
0.15
0.16
0.17
0.17
0.65
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0.24
0.24
0.24
0.22
0.21
0.2
0.87
Long term debt to total equity ratio
0.77
0.77
0.73
0.69
0.59
0.54
2.55
Per share metrics
Operating cash flow per share
0.64
0.82
1.75
3.73
2.09
1.43
9
EBIT per share
3.97
-0.32
0.7
0.75
1.06
1.34
3.85
EBITDA per share
5.5
3.98
2.89
2.95
3.11
6.31
15.26
Total debt per share
—
—
—
—
—
—
—
Cash per share
7.47
7.5
7.47
10.72
12.45
13.45
44.1
Net current asset value per share
26.87
27.32
26.75
29.67
33.11
35.48
125.02
Tangible book value per share
-11.56
-10.26
-9.01
-7.1
-2.68
-0.06
-18.84
Working capital per share
17.08
17.29
16.69
18.01
20.28
22.38
77.36
Book value per share
20.92
20.9
20.88
21.51
23.98
25.47
91.84
新闻
RCKT's Q4 Loss Narrower Than Estimated, Pipeline in Focus
PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View
TGTX Q4 Earnings Lag Estimates, Briumvi Sales Drive Top Line
PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View
ANI制药2025年第四季度业绩:罕见病转型推动营收增长44%
ANI Pharma Q4 2025 slides: rare disease shift drives 44% revenue growth
ANI PharmaceuticalsQ4每股收益及营收超出预期
ANI Pharma earnings beat by $0.36, revenue topped estimates
ANI Pharmaceuticals Turns Profit, Rare Disease Sales Surge 50% - ANI Pharmaceuticals (NASDAQ:ANIP)
Brightspring Health Services, BASF, Swiss Re and more set to report Friday
Viatris Q4 EPS Tops, Brands Drive Revenue Growth, Stock Up
ANI Pharmaceuticals set to report earnings as Cortrophin drives shift